Our Latest New
1st medical device approved for the treatment of fibromyalgia
Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain has obtained medical device status in Europe for its millimeter wave endorphin stimulator wristband. This achievement marks a major advance in care for the millions of patients suffering from fibromyalgia. Obtaining European medical device status for the
1st medical device approved for the treatment of fibromyalgia
Remedee Labs, a French start-up that specializes in non-pharmacological treatments for chronic pain has obtained medical device status in Europe
Remedee Labs announces positive results from its clinical trial on osteoarthritis.
Remedee Labs, a French startup that specializes in non-pharmaceutical treatments for chronic pain, is announcing the highly anticipated results of
Remedee Labs strengthens its Board of Directors and Advisory Board with the arrival of Florence DUPRÉ and Julie FOSTER
Remedee Labs, a French start-up that specializes in non-pharmaceutical chronic pain management and just announced the positive results of its
UPSA and Remedee Labs announce a partnership
February 1st, 2023 – Today, the French pharmaceutical company UPSA and the startup Remedee Labs are announcing the signature of a
Remedee Labs is raising €12.2M
Remedee Labs, a French start-up that specializes in non-pharmaceutical treatments for chronic pain, is announcing a new €12.2 million funding
Remedee Labs joins Future4care
Remedee Labs, a Grenoble-based startup specializing in integrated chronic pain care centered on its unique endorphin stimulation technology, is joining
FDA Grants Breakthrough Device Designation to Remedee Labs
On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough
Gilles LITMAN, former VP of Digital Health at Sanofi, joins Remedee Labs
French health tech startup Remedee Labs, designer of the first endorphin stimulator for personal use, is hiring Gilles Litman to
Remedee Labs joins the 2020 MedTech Innovator Accelerator program
MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Their mission
Remedee Labs starts a study with CEA Clinatec
The challenge of measuring endorphin levels The analgesic effect of millimeter wave (MMW) therapy is due to the release of
$11 million in funding to accelerate electronic medication breakthrough
Funding to support new endorphin-stimulation pain therapy clinical trial Meylan, France, – 14 November 2019 – French startup Remedee Labs